v3.25.1
Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Total revenues $ 44,018 $ 37,736 $ 160,953
Total cost of revenues 23,269 20,985 90,986
Gross profit 20,749 16,751 69,967
Research and development expenses 4,246 4,295 15,185
Selling and marketing expenses 4,510 4,631 18,428
General and administrative expenses 4,198 3,786 15,702
Other expenses 601
Operating income (loss) 7,795 4,039 20,051
Financial income 534 280 2,118
Income (expenses) in respect of currency exchange differences and derivatives instruments, net 251 124 (94)
Financial Income (expense) in respect of contingent consideration and other long- term liabilities. (1,775) (1,845) (8,081)
Financial expenses (192) (159) (660)
Income before tax on income 6,613 2,439 13,334
Taxes on income (2,649) (74) 1,128
Net Income (loss) 3,964 2,365 14,462
Other Comprehensive Income (loss):      
Gain (loss) on cash flow hedges (114) (71) (30)
Net amounts transferred to the statement of profit or loss for cash flow hedges (54) (57) (59)
Items that will not be reclassified to profit or loss in subsequent periods:      
Remeasurement gain (loss) from defined benefit plan 8 7 89
Total comprehensive income (loss) $ 3,804 $ 2,244 $ 14,462
Earnings per share attributable to equity holders of the Company:      
Basic net earnings per share (in Dollars per share) $ 0.07 $ 0.04 $ 0.25
Diluted net earnings per share (in Dollars per share) $ 0.07 $ 0.04 $ 0.25
Proprietary Products [Member]      
Total revenues $ 40,017 $ 33,758 $ 141,447
Total cost of revenues 19,738 17,620 73,708
Gross profit 20,279 16,138 67,739
Distribution [Member]      
Total revenues 4,001 3,978 19,506
Total cost of revenues 3,531 3,365 17,278
Gross profit $ 470 $ 613 $ 2,228